Despite huge advances in interventional cardiology, as a specialty we remain rooted in the immediate: most novel devices are assessed at short-term time points with low-frequency clinical endpoints that have to be combined into composites in order to provide a reasonable chance of demonstrating either noninferiority or superiority [1,2]. As far as longer-term patient prognosis goes, percutaneous coronary intervention (PCI) provides at best a modest impact, with benefits largely confined to patients with substantial ischemic burden  or acute ST-elevation myocardial infarction .
|Title of host publication||Bioresorbable Scaffolds|
|Subtitle of host publication||From Basic Concept to Clinical Applications|
|Editors||Yoshinobu Onuma, Patrick W.J.C. Serruys|
|Place of Publication||Boca Raton|
|Number of pages||9|
|Publication status||Published - 1 Jan 2017|